Here are 4 bullish charts in the medical and biotech arena, which is starting to heat up again.
Exelixis, which has been in a declining wedge off its September top, made a new low for the move intraday on Tuesday before snapping back to close up 39 cents, or 3.68%, to $10.98, on 4.6 million shares. That’s the best volume in two weeks for the company, which is set to report third-quarter results tomorrow. Watch for a pop out of the falling wedge towards next resistance in the 12 range.
